EUVIMEDEUVIMED entdecken
Crossref

Research on the mechanism of notoginsenoside in the treatment of colon cancer based on network pharmacology

Wei-Jia Gao

Integrate Medicine · 31.12.2024

DOI: 10.61958/impy7631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Integrate Medicine, online erschienen am 31.12.2024. Verfasst von Wei-Jia Gao. Die Arbeit nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colon cancer is the third leading cause of cancer-related mortality worldwide. Panax notoginseng saponin, a saponin compound extracted from the root of Panax notoginseng, has demonstrated significant anti-inflammatory and anti-tumor properties. This study aimed to perform a comprehensive bioinformatics analysis to identify the pharmacological targets and effects of notoginseng saponins in colon tissue and colon cancer.

Methods

Data for normal colon tissue, colon cancer, and notoginseng saponins were sourced from GeneCards, Herb, and ETCM databases. Bioinformatics tools, including Jvenn, STRING, and Metascape, were employed to analyze and visualize relationships. Additionally, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and protein-protein interaction (PPI) analyses were conducted on identified intersected targets. Cytoscape were utilized for network visualization.

Results

The Venn diagram highlighted shared biomarkers, offering insights into the molecular pathways affected by notoginseng saponins in colon cancer. PPI network and KEGG pathways analyses identified central hub proteins, including AKT serine/threonine kinase 1 (AKT1), nuclear factor kappa B subunit 1 (NFKB1), and B-cell lymphoma 2 (BCL2), as well as high MCC scoring proteins, such as caspase-3 (CASP3) and mitogen-activated protein kinase 1 (MAPK1), underscoring their pivotal role in cancer biology and regulation by Panax notoginseng saponins.

Conclusions

This study identified potential pharmacological targets of Panax notoginseng saponins in colon cancer. These findings enhance our understanding of the therapeutic mechanisms of Panax notoginseng saponins and their potential clinical applications in treating colon cancer.

Zitieren

APA

Gao, W. (2024). Research on the mechanism of notoginsenoside in the treatment of colon cancer based on network pharmacology. Integrate Medicine. https://doi.org/10.61958/impy7631

Vancouver

Gao W. Research on the mechanism of notoginsenoside in the treatment of colon cancer based on network pharmacology. Integrate Medicine. 2024. doi:10.61958/impy7631

BibTeX
@article{Gao2024,
  author = {Gao, Wei-Jia},
  title = {Research on the mechanism of notoginsenoside in the treatment of colon cancer based on network pharmacology},
  journal = {Integrate Medicine},
  year = {2024},
  doi = {10.61958/impy7631}
}
Kostenlos starten →